Diacerein
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Diacerein.svg | |
| Diacerein
| |
| Systematic (IUPAC) name | |
| 4,5-diacetyloxy-9,10-dioxo-anthracene-2- carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C19H12O8 |
| Mol. mass | 368.294 g/mol |
| Synonyms | Diacetylrhein, diacerhein |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 99% |
| Metabolism | Hepatic: deacetylation to rhein, later glucuronidation and sulfate conjugation |
| Half life | 4 to 5 hours |
| Excretion | Renal (30%) |
| Therapeutic considerations | |
| Pregnancy cat. |
Lacking information |
| Legal status | |
| Routes | Oral |
Diacerein (INN), also known as diacetylrhein, is a drug used in the treatment of osteoarthritis. It works by inhibiting interleukin-1.
A 2005 Cochrane review found diacerein to be slightly, but significantly, more effective than placebo in controlling the pain of osteoarthritis.[1]
Side effects
The most common side effects of diacerein treatment are gastrointestinal, such as diarrhea.[1][1]
References
